Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "infection"

662 News Found

Themis Medicare’s VIRALEX effective against viral respiratory infections
News | July 10, 2022

Themis Medicare’s VIRALEX effective against viral respiratory infections

Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.


Cortexyme announces preclinical data demonstrating efficacy of COR803 for Covid infections
News | June 22, 2022

Cortexyme announces preclinical data demonstrating efficacy of COR803 for Covid infections

COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.


Glenmark launches Whatsapp based chatbot-‘Hello Skin’ for patients suffering from fungal infections
News | May 24, 2022

Glenmark launches Whatsapp based chatbot-‘Hello Skin’ for patients suffering from fungal infections

'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)


Dr Mansukh Mandaviya promises to introduce `Made in India’ TB infection skin test kit
Public Health | May 19, 2022

Dr Mansukh Mandaviya promises to introduce `Made in India’ TB infection skin test kit

This cost-effective tool will be of immense benefit to other high burden countries as well.


USFDA clears Abbott’s test to detect four sexually transmitted infections simultaneously
Drug Approval | May 06, 2022

USFDA clears Abbott’s test to detect four sexually transmitted infections simultaneously

Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity m system, which provides fast results in high volumes – detecting four infections simultaneously


U.S. FDA approves first treatment for drug-resistant post-transplant infection
Drug Approval | November 24, 2021

U.S. FDA approves first treatment for drug-resistant post-transplant infection

The approval is for Cytomegalovirus, a type of Herpes virus


Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis
Biotech | October 14, 2021

Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis

Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations


Technology to distinguish between bacterial and viral infections cleared
Medical Device | September 21, 2021

Technology to distinguish between bacterial and viral infections cleared

MeMed BV is a first-of-its-kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes


FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens
Drug Approval | June 21, 2026

FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens

The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections


J.P. Nadda reviews dengue and malaria preparedness across India
Policy | June 19, 2026

J.P. Nadda reviews dengue and malaria preparedness across India

Union Health Minister calls for heightened vigilance, stronger public awareness campaigns, and district-specific action plans for the high-transmission season